Abstract
Despite years of concerted research, gynecological malignancies have remained a persistent cause of morbidity and mortality in females across the globe. Nearly asymptomatic initial phases render gynecological cancers difficult to be diagnosed during the early stages, further complicating scopes for therapeutic intervention and disease combat. Based on several studies and advancements, oxidative stress has emerged as a prime regulator of myriad events contributing to cancer progression. The mitochondrion is the major site for intrinsic oxidative stress generation, whereas extrinsic factors include UV irradiation, alcohol, pollutants, etc. The manifestation of oxidative stress-induced cancer progression is through different reactive species of which the reactive oxygen species (ROS) is the most abundant. ROS functions as the key regulator of REDOX imbalance, and the underlying oncogenic events, as per reports, exert dual role by exhibiting both tumor suppressing and tumor promoting functions. Low levels of ROS mainly exert cytotoxic effects on tumor cells, whereas fairly increased ROS levels contribute to cancer progression majorly by remodeling the microenvironment niche, rewiring the cellular bioenergetics, and altering the signaling events. The intricacies of ROS imbalance and the paradigm of its functional relevance in gynecological cancer progression cumulatively emphasize on the need for the understanding of the detailed mechanism therein. This chapter aims at underlining different aspects of mitochondrial dysfunction and oxidative stress that promote oncogenesis, intending to pave ways for newer and effective therapeutic interventions.
Similar content being viewed by others
References
Ackerman D, Simon MC (2014) Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment. Trends Cell Biol 24:472–478
Agbor TA, Alex C, Katrina MC, Carsten CS, Ulrike B, Ambrose C, Eoin PC, Gerard C, Cormac TT (2011) Small Ubiquitin-related Modifier (SUMO)-1 Promotes Glycolysis in Hypoxia. J Biol Chem 286(6):4718–4726
Aggarwal V, Tuli HS, Varol A et al (2019) Role of reactive oxygen species in cancer progression: molecular mechanisms and recent advancements. Biomol Ther 9:735
Almeida M, Han L, Martin-Millan M et al (2007) Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting beta-catenin from T cell factor- to forkhead box O-mediated transcription. J Biol Chem 282:27298–27305
Arcucci A, Ruocco MR, Granato G et al (2016) Cancer: an oxidative crosstalk between solid tumor cells and cancer associated fibroblasts. Biomed Res Int 2016:4502846
Bell EL, Emerling BM, Ricoult SJH et al (2011) SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production. Oncogene 30:2986–2996
Burdick AD, Davis JW, Liu KJ et al (2003) Benzo (a) pyrene quinones increase cell proliferation, generate reactive oxygen species, and transactivate the epidermal growth factor receptor in breast epithelial cells. Cancer Res 63:7825–7833
Chan DW, Liu VW, Tsao GS et al (2008) Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells. Carcinogenesis 29:1742–1750
Chen Y, Yang Y, Miller ML et al (2007) Hepatocyte-specific Gclc deletion leads to rapid onset of steatosis with mitochondrial injury and liver failure. Hepatology 45:1118–1128
Chen X, Qian Y, Wu S (2015) The Warburg effect: evolving interpretations of an established concept. Free Radic Biol Med 79:253–263
Chen Q, Yang Y, Lin X et al (2018) Platinum (iv) prodrugs with long lipid chains for drug delivery and overcoming cisplatin resistance. Chem Commun 54:5369–5372
Chen H, Wang J, Feng X et al (2019) Mitochondria-targeting fluorescent molecules for high efficiency cancer growth inhibition and imaging. Chem Sci 10:7946–7951
Chetram MA, Danaya AB, Odero-Marah VA, Don-Salu-Hewage AS, Jones KJ, Hinton CV (2013) ROS-mediated activation of AKT induces apoptosis via pVHL in prostate cancer cells. Mol Cell Biochem 376(1–2):63–71
Chou WC, Jie C, Kenedy AA et al (2004) Role of NADPH oxidase in arsenicinduced reactive oxygen species formation and cytotoxicity in myeloid leukemia cells. Proc Natl Acad Sci 101:4578–4583
Chowdhury SR, Ray U, Chatterjee BP et al (2017) Targeted apoptosis in ovarian cancer cells through mitochondrial dysfunction in response to Sambucus nigra agglutinin. Cell Death Dis 8:e2762
Diebold I, Petry A, Djordjevic T et al (2010) Reciprocal regulation of Rac1 and PAK-1 by HIF-1alpha: a positive-feedback loop promoting pulmonary vascular remodeling. Antioxid Redox Signal 13:399–412
Diehn M, Cho RW, Lobo NA et al (2009) Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458:780–783
Ding N, Zhang H, Su S et al (2018) Emodin enhances the chemosensitivity of endometrial cancer by inhibiting ROS-mediated cisplatin-resistance. Anticancer Agents Med Chem 18:1054–1063
Ghoneum A, Afify H, Salih Z et al (2018) Role of tumor microenvironment in ovarian cancer pathobiology. Oncotarget 9:22832
Griffith OW, Meister A (1979) Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (Sn-butyl homocysteine sulfoximine). J Biol Chem 254:7558–7560
Hojo T, Maishi N, Towfik AM et al (2017) ROS enhance angiogenic properties via regulation of NRF2 in tumor endothelial cells. Oncotarget 8:45484–45495
Idelchik MDPS, Begley U, Begley TJ et al (2017) Mitochondrial ROS control of cancer. Semin Cancer Biol 47:57–66
Ježek J, Cooper KF, Strich R (2018) Reactive oxygen species and mitochondrial dynamics: the yin and yang of mitochondrial dysfunction and cancer progression. Antioxidants 7:13
Kashyap D, Sharma A, Garg V et al (2016) Reactive oxygen species (ROS): an activator of apoptosis and autophagy in cancer. J Biol Chem Sci 3:256–264
Kim J, Kim J, Bae JS (2016) ROS homeostasis and metabolism: a critical liaison for cancer therapy. Exp Mol Med 48:e269–e269
Kim EK, Jang M, Song MJ et al (2019) Redox-mediated mechanism of Chemoresistance in Cancer cells. Antioxidants 8:471
Klimova T, Chandel NS (2008) Mitochondrial complex III regulates hypoxic activation of HIF. Cell Death Different 15:660–666
Klotz LO, Sánchez-Ramos C, Prieto-Arroyo I et al (2015) Redox regulation of FoxO transcription factors. Redox Biol 6:51–72
Kudryavtseva AV, Krasnov GS, Dmitriev AA et al (2016) Mitochondrial dysfunction and oxidative stress in aging and cancer. Oncotarget 7:44879–44905
Kumari S, Badana AK, Malla R (2018) Reactive oxygen species: a key constituent in cancer survival. Biomark Insights 13:1177271918755391
Lander HM, Hajjar DP, Hempstead BL et al (1997) A molecular redox switch on p21ras structural basis for the nitric oxide-p21ras interaction. J Biol Chem 272:4323–4326
Liou GY, Storz P (2010) Reactive oxygen species in cancer. Free Radic Res 44:479–496
Liu LZ, Hu XW, Xia C (2006) Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1α expression through activation of AKT and P70S6K1 in human ovarian cancer cells. Free Radic Biol Med 41:1521–1533
Maiti AK (2010) Gene network analysis of oxidative stress-mediated drug sensitivity in resistant ovarian carcinoma cells. Pharmacogenomics J 10:94–104
Marullo R, Werner E, Degtyareva N et al (2013) Cisplatin induces a mitochondrial- ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions. PLoS One 8:e81162
Maya-Mendoza A, Ostrakova J, Kosar M et al (2015) Myc and Ras oncogenes engage different energy metabolism programs and evoke distinct patterns of oxidative and DNA replication stress. Mol Oncol 9:601–616
McCubrey JA, Steelman LS, Chappell et al (2007) Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta Mol Cell Res 1773:1263–1284
Meng Y, Chen CW, Yung MM et al (2018) DUOXA1-mediated ROS production promotes cisplatin resistance by activating ATR-Chk1 pathway in ovarian cancer. Cancer Lett 428:104–116
Mochizuki T, Furuta S, Mitsushita J et al (2006) Inhibition of NADPH oxidase 4 activates apoptosis via the AKT/apoptosis signal-regulating kinase 1 pathway in pancreatic cancer PANC-1 cells. Oncogene 25:3699–3707
Moulder S, Dhillon N, Ng C, Boytim M et al (2010) A phase I trial of imexon, a pro-oxidant, in combination with docetaxel for the treatment of patients with advanced breast, non-small cell lung and prostate cancer. Invest New Drugs 28:634–640
Nelson KK, Melendez JA (2004) Mitochondrial redox control of matrix metalloproteinases. Free Radic Biol Med 37:768–784
Nguyen H, Syed V (2011) Progesterone inhibits growth and induces apoptosis in cancer cells through modulation of reactive oxygen species. Gynecol Endocrinol 27:830–836
Pastò A, Bellio C, Pilotto G et al (2014) Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation. Oncotarget 5:4305–4319
Pavlova NN, Thompson CB (2016) The emerging hallmarks of cancer metabolism. Cell Metab 23:27–47
Pešić M, Podolski-Renić A, Stojković S et al (2015) Anti-cancer effects of cerium oxide nanoparticles and its intracellular redox activity. Chem Biol Interact 232:85–93
Piersma SJ (2011) Immunosuppressive tumor microenvironment in cervical cancer patients. Cancer Microenviron 4:361–375
Ray U, Roy SS (2018) Aberrant lipid metabolism in cancer cells–the role of oncolipid-activated signaling. FEBS J 285:432–443
Sabharwal SS, Schumacker PT (2014) Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles’ heel? Nat Rev Cancer 14:709–721
Sack M, Alili L, Karaman E et al (2014) Combination of conventional chemotherapeutics with redox-active cerium oxide nanoparticles – a novel aspect in cancer therapy. Mol Cancer Ther 13:1740–1749
Sahoo SS, Zhang XD, Hondermarck H, Tanwar PS (2018) The emerging role of the microenvironment in endometrial cancer. Cancers 10:408
Schröder K, Zhang M, Benkhoff S et al (2012) Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circ Res 110:1217–1225
Silva GÁF, Nunes RAL, Morale MG et al (2018) Oxidative stress: therapeutic approaches for cervical cancer treatment. Clinics 73:e548s
Simic MG, Bergtold DS, Karam LR (1989) Generation of oxy radicals in biosystems. Mutat Res/Fund Mol Mech Mutag 214:3–12
Singh PK, Brand RE, Mehla K (2012) MicroRNAs in pancreatic cancer metabolism. Nat Rev Gastroenterol Hepatol 9:334
Sosa V, Moliné T, Somoza R et al (2013) Oxidative stress and cancer: an overview. Ageing Res Rev 12:376–390
Tello D, Balsa E, Acosta-Iborra B et al (2011) Induction of the mitochondrial NDUFA4L2 protein by HIF-1α decreases oxygen consumption by inhibiting Complex I activity. Cell Metab 14:768–779
Turrens JF (2003) Mitochondrial formation of reactive oxygen species. J Physiol 552:335–344
Wallace DC (2012) Mitochondria and cancer. Nat Rev Cancer 12:685–698
Wang Y, Ma J, Shen H et al (2014) Reactive oxygen species promote ovarian cancer progression via the HIF-1α/LOX/E-cadherin pathway. Oncol Rep 32:2150–2158
Wang M, Zhao J, Zhang L et al (2017) Role of tumor microenvironment in tumorigenesis. J Cancer 8:761–773
Wang Y, Branicky R, Noë A, Hekimi S (2018a) Superoxide dismutases: dual roles in controlling ROS damage and regulating ROS signaling. J Cell Biol 217:1915–1928
Wang YY, Chen J, Liu XM et al (2018b) Nrf2-mediated metabolic reprogramming in cancer. Oxidative Med Cell Longev 2018:9304091
Wang H, Wang J, Liu H et al (2019) TGF-β1 activates NOX4/ROS pathway to promote the invasion and migration of cervical cancer cells. Chin J Cell Mol Immunol 35:121–127
Weinberg F, Ramnath N, Nagrath D (2019) Reactive oxygen species in the tumor microenvironment: an overview. Cancers 11:1191
Wen Y, Clark PM, Mason DE, Keenan MC, Hill C, Goddard III, WA, Peters EC, Driggers EM, Hsieh-Wilson LC (2012) PFK1 glycosylation is a key regulator of cancer cell growth and central metabolic pathways. Science (New York, NY), 337(6097), p.975.
White M, Cohen J, Hummel C et al (2014) The role of oxidative stress in ovarian cancer: implications for the treatment of patients. Cancer 5:41–50
Xiao D, Powolny A, Moura MB et al (2010) Phenethyl isothiocyanate inhibits oxidative phosphorylation to trigger reactive oxygen species-mediated death of human prostate cancer cells. J Biol Chem 285:26558–26569
Yang H, Villani RM, Wang H et al (2018) The role of cellular reactive oxygen species in cancer chemotherapy. J Exp Clin Cancer Res 37:266
Zhang W, Hu X, Shen Q et al (2019) Mitochondria-specific drug release and reactive oxygen species burst induced by polyprodrug nanoreactors can enhance chemotherapy. Nat Commun 10:1–14
Zhao Y, Tang S, Guo J et al (2017) Targeted delivery of doxorubicin by nano-loaded mesenchymal stem cells for lung melanoma metastases therapy. Sci Reports 7:1–12
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this entry
Cite this entry
Ghosh, D., Chatterjee, P., Mitra, T., Roy, S.S. (2021). Association of Oxidative Stress and Mitochondrial Dysfunction to Gynecological Malignancies. In: Chakraborti, S., Ray, B.K., Roychowdhury, S. (eds) Handbook of Oxidative Stress in Cancer: Mechanistic Aspects. Springer, Singapore. https://doi.org/10.1007/978-981-15-4501-6_15-1
Download citation
DOI: https://doi.org/10.1007/978-981-15-4501-6_15-1
Received:
Accepted:
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-4501-6
Online ISBN: 978-981-15-4501-6
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences